Tested Applications
| Positive WB detected in | human saliva tissue, K-562 cells |
| Positive IHC detected in | human colon cancer tissue, human breast cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
10376-1-AP targets LPO in WB, IHC, IF, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
peptide Predict reactive species |
| Full Name | lactoperoxidase |
| Calculated Molecular Weight | 80 kDa |
| Observed Molecular Weight | 80 kDa |
| GenBank Accession Number | BC107167 |
| Gene Symbol | LPO |
| Gene ID (NCBI) | 4025 |
| RRID | AB_2877734 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P22079 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for LPO antibody 10376-1-AP | Download protocol |
| WB protocol for LPO antibody 10376-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
Anti-TPO (Thyroid Peroxidase) antibody, catalog number 10376-1-AP, has 8 total citations. These appear in Nature Aging, Cell Death Discovery, Diabetologia, Frontiers in Cell and Developmental Biology, FASEB Journal, Free Radical Research, and PLoS One. Research fields span thymus function and mTOR signaling, podocyte ferroptosis, diabetes and metformin therapy, colon cancer prognosis, atherosclerosis, fatty liver disease, and thyroid/breast tissue TPO characterization.
| Species | Application | Title |
|---|---|---|
Nat Aging Paracrine FGF21 dynamically modulates mTOR signaling to regulate thymus function across the lifespan | ||
Cell Death Discov MAPK14/SLC7A11/GPX4 axis dysregulation drives podocyte ferroptosis via mediating glycerophospholipid metabolism. | ||
Diabetologia Metformin protects podocytes by inhibiting the MAPK14-SLC7A11-GPX4 axis and dysregulation of fatty acid metabolism. | ||
Front Cell Dev Biol Identification and verification of a prognostic signature based on a miRNA-mRNA interaction pattern in colon adenocarcinoma | ||
FASEB J Melatonin suppresses atherosclerosis by ferroptosis inhibition via activating NRF2 pathway | ||
Free Radic Res Metformin suppresses metabolic dysfunction-associated fatty liver disease by ferroptosis and apoptosis via activation of oxidative stress |









